CSRxP Statement On House & Senate Committee Hearings On Skyrocketing Drug Prices

01-29-2019 Press Release

For Immediate Release: Contact: Lauren Blair (201) 213-5004 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) executive director, Lauren Aronson, today released the following statement after the U.S. House Oversight and Reform and U.S. Senate Finance Committees held their first hearings on drug pricing: “We appreciate the commitment of Senate Finance Committee […]

SHOT/CHASER: Pfizer & Novartis Double-Talk On Price Increases For Drugs Most Important To Bottom Lines

01-28-2019 Press Release

For Immediate Release: Contact: Lauren Blair (201) 213-5004 [email protected] SHOT: Pfizer & Novartis Introduce Minor Price Hikes On A Small Portion Of Their Drugs: Pfizer And Novartis Left The Prices To The “Vast Majority” Of Their Portfolios Unchanged. “Pharma giants Pfizer and Novartis have officially raised prices on dozens of drugs, according to data from […]

“WHAT’S PAST IS PROLOGUE” Big Pharma’s Track Record Is A Vast Departure From Its Rhetoric: Part III

01-25-2019 Press Release

In advance of the House and Senate hearings on January 29, 2019, the Campaign for Sustainable Rx Pricing (CSRxP) is rolling out a new blog series on what lawmakers can expect to hear from pharmaceutical companies. Yesterday, we looked at the three biggest makers of insulin in the world, Eli Lily, Novo Nordisk and Sanofi. […]

“WHAT’S PAST IS PROLOGUE” Big Pharma’s Track Record Is A Vast Departure From Its Rhetoric: Part II

01-24-2019 Press Release

In advance of the hearing on January 29, 2019, the Campaign for Sustainable Rx Pricing (CSRxP) is rolling out a new blog series on what lawmakers can expect to hear from pharmaceutical companies. Yesterday, we looked at AbbVie, Celgene and Mallinckrodt. Today, we will look at the rhetoric and track records of Eli Lilly, Novo […]

“WHAT’S PAST IS PROLOGUE” Big Pharma’s Track Record Is A Vast Departure From Its Rhetoric: Part I

01-23-2019 Press Release

For Immediate Release: Contact: Lauren Blair (201) 213-5004 [email protected] With 80 percent of Americans viewing the drug pricing crisis as the top priority for Congress to tackle this year, it should not come as a surprise that the focus of the U.S. House of Representatives Committee on Oversight and Government Reform’s first oversight hearing is out-of-control drug […]

CSRxP Welcomes Coalition Against Patent Abuse To Drug Pricing Conversation

01-16-2019 Press Release

The Campaign for Sustainable Rx Pricing (CSRxP) Communications Director Lauren Blair today issued the following statement applauding the launch of the Coalition Against Patent Abuse, a new multi-stakeholder organization working to protect patients from Big Pharma’s patent abuses, and encourage more generic and biosimilar competition: “Big Pharma knows how to game the patent system to […]

With 116th Congress Commencing, CSRxP Announces New Website Launch To Help Lawmakers Address Drug Pricing Crisis

01-8-2019 Press Release

With ‘taking action to lower drug prices’ becoming Americans’ top priority for the 116th Congress, the Campaign for Sustainable Rx Pricing (CSRxP) launched a new website to help members and their staff better understand the drug price crisis and the bipartisan, market-based solutions needed to make drugs more affordable for all Americans. “Lowering prescription drug prices was […]

SHOT/CHASER: Analysts Suggest Drug Makers Are Changing Their Ways; Drug Makers Increase Prices By Up To 15 Times Rate Of Inflation

01-4-2019 Press Release

For Immediate Release Contact: Lauren Blair (201) 213-5004 [email protected] SHOT: Analysts Suggest Drug Makers Are Changing Their Ways: Analyst Says Industry Appears To Be “Self-Policing.” “Umer Raffat, an analyst at Everscore ISI, said the increases this year appear to be modest, similar to the past couple of years, as the industry adjusts to pressures on […]

Right On Cue, Drug Companies Begin New Year With Major Price Hikes

01-2-2019 Press Release

For Immediate Release Contact: Lauren Blair (201) 213-5004 [email protected] The Campaign for Sustainable Rx Pricing (CSRxP) Communications Director Lauren Blair issued the following statement in response to a new study from RX Savings Solutions that found more than three dozen pharmaceutical companies raised the prices on hundreds of medications earlier this week: “Just like that, […]

CSRxP Responds To Big Pharma’s 2019 Price Hikes

12-20-2018 Press Release

Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued the following statement in response to a report that 30 pharmaceutical companies are expected to increase drug prices next month, which follows Pfizer’s earlier announcement it would revert back to “business as normal”: “This news shouldn’t come as a shock to anyone.  Big Pharma has blinders on and the […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.